Cargando…
E3-ubiquitin ligases and recent progress in osteoimmunology
Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and protea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996189/ https://www.ncbi.nlm.nih.gov/pubmed/36911671 http://dx.doi.org/10.3389/fimmu.2023.1120710 |
_version_ | 1784902990126120960 |
---|---|
author | Asano, Yosuke Matsumoto, Yoshinori Wada, Jun Rottapel, Robert |
author_facet | Asano, Yosuke Matsumoto, Yoshinori Wada, Jun Rottapel, Robert |
author_sort | Asano, Yosuke |
collection | PubMed |
description | Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies. |
format | Online Article Text |
id | pubmed-9996189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99961892023-03-10 E3-ubiquitin ligases and recent progress in osteoimmunology Asano, Yosuke Matsumoto, Yoshinori Wada, Jun Rottapel, Robert Front Immunol Immunology Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies. Frontiers Media S.A. 2023-02-23 /pmc/articles/PMC9996189/ /pubmed/36911671 http://dx.doi.org/10.3389/fimmu.2023.1120710 Text en Copyright © 2023 Asano, Matsumoto, Wada and Rottapel https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Asano, Yosuke Matsumoto, Yoshinori Wada, Jun Rottapel, Robert E3-ubiquitin ligases and recent progress in osteoimmunology |
title | E3-ubiquitin ligases and recent progress in osteoimmunology |
title_full | E3-ubiquitin ligases and recent progress in osteoimmunology |
title_fullStr | E3-ubiquitin ligases and recent progress in osteoimmunology |
title_full_unstemmed | E3-ubiquitin ligases and recent progress in osteoimmunology |
title_short | E3-ubiquitin ligases and recent progress in osteoimmunology |
title_sort | e3-ubiquitin ligases and recent progress in osteoimmunology |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996189/ https://www.ncbi.nlm.nih.gov/pubmed/36911671 http://dx.doi.org/10.3389/fimmu.2023.1120710 |
work_keys_str_mv | AT asanoyosuke e3ubiquitinligasesandrecentprogressinosteoimmunology AT matsumotoyoshinori e3ubiquitinligasesandrecentprogressinosteoimmunology AT wadajun e3ubiquitinligasesandrecentprogressinosteoimmunology AT rottapelrobert e3ubiquitinligasesandrecentprogressinosteoimmunology |